Literature DB >> 333643

Prophylaxis of deep venous thrombosis by hydroxychloroquine sulfate and heparin.

T K Wu, M J Tsapogas, F R Jordan.   

Abstract

A double blind study of 134 patients was undertaken to compare the effectiveness of hydroxychloroquine sulfate, Plaquenil, and heparin in the prophylaxis of deep venous thrombosis. By the 125I fibrinogen scanning technique, deep venous thrombosis was detected in six patients in the placebo group, in one patient in the Plaquenil group and none in the heparin group. These results indicate that both heparin and Plaquenil do diminish the incidence of thrombosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 333643

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  12 in total

Review 1.  Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.

Authors:  Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

2.  Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice.

Authors:  Mitchell R Dyer; Wyeth Alexander; Adnan Hassoune; Qiwei Chen; Tomasz Brzoska; Jurgis Alvikas; Yingjie Liu; Shannon Haldeman; Will Plautz; Patricia Loughran; Hui Li; Brian Boone; Yoel Sadovsky; Prithu Sundd; Brian S Zuckerbraun; Matthew D Neal
Journal:  J Thromb Haemost       Date:  2019-07-28       Impact factor: 5.824

Review 3.  Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage.

Authors:  Claire de Moreuil; Zarrin Alavi; Elisabeth Pasquier
Journal:  Br J Clin Pharmacol       Date:  2019-12-17       Impact factor: 4.335

4.  Prophylaxis of venous thromboembolism: analysis of cost effectiveness.

Authors:  E W Salzman; G C Davies
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

Review 5.  Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis.

Authors:  Lisa N Guo; Vinod E Nambudiri
Journal:  Clin Rheumatol       Date:  2020-07-05       Impact factor: 2.980

Review 6.  Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?

Authors:  Kimberly Janet Legault; Amaia Ugarte; Mark Andrew Crowther; Guillermo Ruiz-Irastorza
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

Review 7.  Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.

Authors:  G P Clagett; J S Reisch
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

8.  Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients.

Authors:  Tarun S Sharma; Mary Chester M Wasko; Xiaoqin Tang; Deepak Vedamurthy; Xiaowei Yan; Jonida Cote; Androniki Bili
Journal:  J Am Heart Assoc       Date:  2016-01-04       Impact factor: 5.501

9.  Efficacy and safety of hydroxychloroquine as add-on therapy in uncontrolled type 2 diabetes patients who were using two oral antidiabetic drugs.

Authors:  H N Chakravarti; A Nag
Journal:  J Endocrinol Invest       Date:  2020-06-27       Impact factor: 4.256

Review 10.  Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview.

Authors:  Roberta Gualtierotti; Marco Parisi; Francesca Ingegnoli
Journal:  Adv Ther       Date:  2018-03-20       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.